These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17070661)

  • 1. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
    Werle M; Kafedjiiski K; Kolmar H; Bernkop-Schnürch A
    Int J Pharm; 2007 Mar; 332(1-2):72-9. PubMed ID: 17070661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery.
    Werle M; Schmitz T; Huang HL; Wentzel A; Kolmar H; Bernkop-Schnürch A
    J Drug Target; 2006 Apr; 14(3):137-46. PubMed ID: 16753827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
    Marschütz MK; Bernkop-Schnürch A
    Biomaterials; 2000 Jul; 21(14):1499-507. PubMed ID: 10872779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the barrier caused by luminally secreted gastro-intestinal proteolytic enzymes for two novel cystine-knot microproteins.
    Werle M; Kolmar H; Albrecht R; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):195-200. PubMed ID: 17619117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot.
    Colgrave ML; Craik DJ
    Biochemistry; 2004 May; 43(20):5965-75. PubMed ID: 15147180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
    Craik DJ; Clark RJ; Daly NL
    Expert Opin Investig Drugs; 2007 May; 16(5):595-604. PubMed ID: 17461734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Expression of Cyclotides Using Expressed Protein Ligation.
    Campbell MJ; Su J; Camarero JA
    Methods Mol Biol; 2020; 2133():327-341. PubMed ID: 32144675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oral oligonucleotide delivery system based on a thiolated polymer: Development and in vitro evaluation.
    Martien R; Hoyer H; Perera G; Schnürch AB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):355-60. PubMed ID: 21295141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
    Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack.
    Bernkop-Schnürch A; Pasta M
    J Pharm Sci; 1998 Apr; 87(4):430-4. PubMed ID: 9548894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative folding of the cystine knot motif in cyclotide proteins.
    Craik DJ; Daly NL
    Protein Pept Lett; 2005 Feb; 12(2):147-52. PubMed ID: 15723640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins.
    Ireland DC; Colgrave ML; Nguyencong P; Daly NL; Craik DJ
    J Mol Biol; 2006 Apr; 357(5):1522-35. PubMed ID: 16488428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF; Hombach J; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insecticidal plant cyclotides and related cystine knot toxins.
    Gruber CW; Cemazar M; Anderson MA; Craik DJ
    Toxicon; 2007 Mar; 49(4):561-75. PubMed ID: 17224167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barnase fusion as a tool to determine the crystal structure of the small disulfide-rich protein McoEeTI.
    Niemann HH; Schmoldt HU; Wentzel A; Kolmar H; Heinz DW
    J Mol Biol; 2006 Feb; 356(1):1-8. PubMed ID: 16337652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
    Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
    J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.